Race/Ethnicity in Atrial Fibrillation Stroke: Epidemiology and Pharmacotherapy

Keith C Ferdinand1, Gary A Puckrein2

  • 1Clinical Medicine, Tulane University School of Medicine.

Insights

This study highlights the importance of professional writing assistance in scientific publications. Funding for editorial services ensures adherence to high-quality standards in medical research communication.

Area of Science:

  • Medical writing and editorial services
  • Pharmaceutical industry funding
  • Authorship and publication ethics

Background:

  • The critical role of professional editorial support in scientific manuscript development.
  • The influence of pharmaceutical funding on research publication processes.
  • Adherence to International Committee of Medical Journal Editors (ICMJE) authorship criteria.

Purpose of the Study:

  • To acknowledge and detail the editorial assistance received for manuscript preparation.
  • To affirm the authors' full responsibility and control over content and editorial decisions.
  • To ensure transparency regarding funding sources for editorial services.

Main Methods:

  • Authorship criteria assessment based on ICMJE guidelines.
  • Documentation of editorial assistance and funding sources.
  • Confirmation of authorial control over all manuscript development stages.

Main Results:

  • Editorial assistance was provided by Rosemary Perkins of Envision Pharma Group.
  • Funding for editorial services was provided by Boehringer Ingelheim Pharmaceuticals, Inc.
  • Authors confirmed full responsibility and adherence to ICMJE criteria.

Conclusions:

  • Professional editorial support, when appropriately funded and acknowledged, enhances scientific manuscript quality.
  • Transparency in acknowledging funding for editorial services is crucial for maintaining research integrity.
  • Authorship and editorial control remain firmly with the researchers, ensuring unbiased scientific communication.

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
113
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
98
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
569
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
456
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K